advertisement
Torp-Pedersen C 11
Showing records 1 to 11 | Display all abstracts from Torp-Pedersen C117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Niazi S
Ophthalmology 2024; 131: 1056-1063
117799 Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study
Horwitz A
PLoS ONE 2023; 18: e0292439
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Gnesin F
Ophthalmology 2024; 131: 1056-1063
117799 Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study
Klemp M; Rovelt J
PLoS ONE 2023; 18: e0292439
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Thein AS
Ophthalmology 2024; 131: 1056-1063
117799 Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study
Horwitz H
PLoS ONE 2023; 18: e0292439
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Andreasen JR
Ophthalmology 2024; 131: 1056-1063
117799 Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study
Torp-Pedersen C
PLoS ONE 2023; 18: e0292439
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Horwitz A
Ophthalmology 2024; 131: 1056-1063
117799 Inferring glaucoma status from prescriptions, diagnoses, and operations data: A Danish nationwide study
Kolko M
PLoS ONE 2023; 18: e0292439
117791 Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Mouhammad ZA; Jawad BN; Niazi Z; Pourhadi N; Zareini B; Meaidi A; Torp-Pedersen C; Kolko M
Ophthalmology 2024; 131: 1056-1063
